GSK follows Pfizer in meningococcal vaccine race with new FDA nodnews2025-02-15T03:26:57+00:00February 15th, 2025|Endpoints News|
NIH, CDC cuts expected as Trump shakeup hits healthcarenews2025-02-14T21:00:32+00:00February 14th, 2025|Endpoints News|
Drugmakers plan Trump meeting next week amid health shakeupsnews2025-02-14T17:58:32+00:00February 14th, 2025|Endpoints News|
NIH’s funding cut plan poses challenges for researchers despite court haltnews2025-02-12T20:39:24+00:00February 12th, 2025|Endpoints News|
Kaiser Permanente calls on FDA and Congress to firm up accelerated approval requirementsnews2025-02-12T20:38:17+00:00February 12th, 2025|Endpoints News|
Pfizer wins approval in new indication for blood cancer drug Adcetrisnews2025-02-12T18:23:41+00:00February 12th, 2025|Endpoints News|
SpringWorks lands FDA approval for nerve tumor treatmentnews2025-02-12T02:25:12+00:00February 12th, 2025|Endpoints News|
Travere plans to seek expanded label for kidney drugnews2025-02-11T20:57:01+00:00February 11th, 2025|Endpoints News|
Biohaven gets FDA priority review for neuro disease drug after refuse-to-filenews2025-02-11T20:50:05+00:00February 11th, 2025|Endpoints News|
FDA puts two Chinese API makers on import alert after failed inspectionsnews2025-02-11T18:24:55+00:00February 11th, 2025|Endpoints News|
